Literature DB >> 29271836

The Economic Burden of Bladder Cancer Due to Occupational Exposure.

Young Long Jung1, Emile Tompa, Christopher Longo, Christina Kalcevich, Joanne Kim, Chaojie Song, Paul Demers.   

Abstract

OBJECTIVE: To estimate the economic burden of bladder cancer due to occupational exposures.
METHODS: Using a societal perspective, we estimate the lifetime costs of newly diagnosed cases of bladder cancer in Canada that is associated with occupational exposure for the calendar year 2011. The three major categories we consider are direct, indirect, and quality of life costs.
RESULTS: There were 199 newly identified cases of bladder cancer. The estimated total cost of bladder cancer for new cases in 2011 was $131 million and an average per-case cost of $658,055 CAD (2011 dollars). Of the total costs, direct costs accounted for 6%, indirect costs 29%, and health-related quality of life costs 65%.
CONCLUSIONS: The per-case economic burden of bladder cancer due to occupational exposure is substantial which suggests the importance and value of exposure reduction.

Entities:  

Mesh:

Year:  2018        PMID: 29271836     DOI: 10.1097/JOM.0000000000001242

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  3 in total

1.  Assessing geographic and industry-related trends in bladder cancer in Ontario: A population-based study.

Authors:  Leandra Stringer; Tina Luu Ly; Nicolas Vanin Moreno; Christopher Macdonald Hewitt; Michael Haan; Nicholas Power
Journal:  Can Urol Assoc J       Date:  2022-02       Impact factor: 1.862

2.  The Economic Burden of Cancer in Canada from a Societal Perspective.

Authors:  Roxanne Garaszczuk; Jean H E Yong; Zhuolu Sun; Claire de Oliveira
Journal:  Curr Oncol       Date:  2022-04-14       Impact factor: 3.109

3.  The psychosocial cost burden of cancer: A systematic literature review.

Authors:  Beverley M Essue; Nicolas Iragorri; Natalie Fitzgerald; Claire de Oliveira
Journal:  Psychooncology       Date:  2020-09-06       Impact factor: 3.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.